Reference : BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on ...
Scientific congresses and symposiums : Poster
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/68730
BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors
English
Hanson, Julien mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Rolin, S. [ > > ]
De Leval, X. [ > > ]
Neven, P. [ > > ]
Masereel, B. [ > > ]
Pirotte, Bernard mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Dogne, J. M. [ > > ]
22-Nov-2003
Yes
International
Réunion de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques
22 novembre 2003
Liège
Belgique
http://hdl.handle.net/2268/68730

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.